Does telmisartan prevent hepatic fibrosis in rats with alloxan-induced diabetes?
Authors:
- Habip BilenHBHabip Bilen
- Fatih AlbayrakFAFatih Albayrak
- Abdullah UyanikAUAbdullah Uyanik
- Ramazan CetinkayaRCRamazan Cetinkaya
- Halis SuleymanHSHalis Suleyman
- Osman Nuri KelesOKOsman Nuri Keles
- Bunyami UnalBUBunyami Unal
- 1 July 2009
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 614 (1-3) , 146-152
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Obesity, Insulin Resistance and Hepatic PerfusionMicrocirculation, 2007
- Analysis of Recent Papers in Hypertension Jan N . Basile, MD, Senior EditorThe Journal of Clinical Hypertension, 2004
- Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating ActivityHypertension, 2004
- Stereological analysis of the mediodorsal thalamic nucleus in schizophrenia: Volume, neuron number, and cell typesJournal of Comparative Neurology, 2004
- Angiotensin II and Nitric Oxide InteractionHeart Failure Reviews, 2002
- Insulin resistance in type 2 diabetes: role of fatty acidsDiabetes/Metabolism Research and Reviews, 2002
- Angiotensin II induces contraction and proliferation of human hepatic stellate cellsGastroenterology, 2000
- Circulating and tissue angiotensin systems.Journal of Clinical Investigation, 1987
- Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat.Journal of Clinical Investigation, 1986
- Effect of angiotensin‐ll blockade on systemic and hepatic haemodynamics and on the renin‐angiotensin‐aldosterone system in cirrhosis with ascitesEuropean Journal of Clinical Investigation, 1981